Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://dx.doi.org/10.1093/ehjci/jeae266DOI Listing

Publication Analysis

Top Keywords

increased 18f-fapi
4
18f-fapi 18f-fdg
4
18f-fdg uptake
4
uptake cardiac
4
cardiac tuberculosis
4
tuberculosis mimicking
4
mimicking malignant
4
malignant tumour
4
increased
1
18f-fdg
1

Similar Publications

Purpose: High-grade gliomas are highly aggressive brain tumors, and precise target volume delineation is crucial for effective treatment. This study aimed to evaluate the concordance and discrepancy between biological tumor volume (BTV) delineated using union of [F]FAPI-42 and [C]methionine and conventional gross tumor volume (GTV) in gliomas.

Methods: Nineteen glioma patients were retrospectively enrolled, who underwent [F]FAPI-42 and [C]methionine PET/MRI before radiation therapy.

View Article and Find Full Text PDF

Objectives: To evaluate the utility of fibroblast activation protein (FAP) imaging using [¹⁸F]FAPI PET/CT for assessing disease activity and monitoring treatment response in rheumatoid arthritis (RA).

Materials And Methods: A prospective, single-center study was conducted with 42 RA patients and 8 healthy controls. Participants underwent clinical assessment and [¹⁸F]FAPI PET/CT imaging.

View Article and Find Full Text PDF

Background: Fluorine 18-labeled fibroblast activation protein inhibitor (F-FAPI-04) positron emission tomography/computed tomography (PET/CT) has shown promise for the visualization of advanced stage lung cancer. The accuracy of F-FAPI-04 compared with that of fluorine-18 labeled-fluorodeoxyglucose (F-FDG) in detecting early lung adenocarcinoma (LUAD) remains unknown. Taking the surgical pathology of pulmonary nodule as the gold standard, the diagnostic performance of stage IA LUAD were compared between F-FAPI-04 PET/CT and F-FDG PET/CT, and the correlation between F-FAPI-04 uptake and pathological characteristics of stage IA LUAD.

View Article and Find Full Text PDF

Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension.

J Nucl Med

January 2025

Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou, China; and 71lu

The purpose of this study was to investigate the feasibility of using F-labeled fibroblast activation protein inhibitor (FAPI) PET/CT in assessing the fibrotic remodeling of the pulmonary artery (PA) and the right ventricle (RV) in pulmonary arterial hypertension (PAH). In a rat model of monocrotaline-induced PAH, rats were euthanized at different time points for tissue analysis (fibroblast activation protein immunofluorescence and Masson's trichrome staining) after completing F-FAPI PET/CT and hemodynamic measurements. Thirty-eight PAH patients were enrolled to participate in F-FAPI PET/CT imaging, with right heart catheterization and echocardiography performed within 1 wk to assess pulmonary hemodynamics and cardiac function.

View Article and Find Full Text PDF